open-navigation
close-navigation

Replenishment

Brief note regarding The Global Fund Replenishment

The Global Fund, also known as The Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM), is a Geneva based multi-lateral funding organization aimed at eliminating and controlling AIDS, TB and Malaria.

The Global Fund raises and invests nearly US$ 4 billion a year from various donors that include countries, the private sector, philanthropists etc to support HIV, TB and Malaria programs run by local experts in countries and communities most in need.

Global Fund raises funding in three-year cycles known as Replenishment and awards grant in three-year cycles known as Grant cycles. India is a donor as well as a recipient of Global Fund grants.

The Global Fund has a sustained partnership with India since 2002, with US $3.6 billion grant disbursed so far for HIV, TB and Malaria disease programmes and C19RM.

There has been a significant impact of Global Fund grants in India, although India is largely self-sufficient in implementing vital life-saving interventions under the HIV, TB and Malaria programmes through domestic funding. Global Fund grants, to the tune of >US $ 500 million in three-year grant cycles, have in past, as well as the current cycle GC7, largely focussed on sustaining the gains made in previous cycles and filling critical gaps to complement the country’s efforts to mitigate these diseases.

India is one of the leading donors from the Global South. Additionally, India’s medical technology and pharmaceutical industry is an indispensable enabler of The Global Fund’s mission. Since 2010, the Global Fund has placed orders with Indian pharmaceutical companies worth about US$11 billion.

As a donor, India has pledged US $93.5 million so far towards Global Fund Replenishment since 2006 as a testament to its Global commitment for Health.

India in the 7th replenishment cycle has pledged an amount of USD 25 million, an addition of 3 million USD more than the last replenishment cycle of USD 22 million in the 6th replenishment cycle. The first two tranches of 8 million USD each have already been disbursed and the third tranche of 9 million USD is due to be disbursed in 2025.

India’s pledge to The Global Fund is summarized in the table given below:

Replenishment CyclePeriodAmount pledged by India (US $)Current status
1st2006- 201110 million10 million
4th2013- 201616.5 millionFully disbursed
5th2017- 201920 million Fully disbursed
6th2020- 202222 millionFully disbursed
7th2023- 202525 millionFully disbursed

Regarding the Global Fund’s 8th Replenishment:

The Global Fund’s 8th Replenishment and Investment Case is virtually launched in 2025 for the fund-raising period (2026-2028), co-hosted by the governments of South Africa and the United Kingdom.

For the Eighth Replenishment, the Global Fund needs US$18 billion to save 23 million lives between 2027 and 2029, reduce the combined mortality rate by another 64%, relative to 2023 levels, and prevent around 400 million infections

Looking at the current global scenario, and in view of the shrinking funding envelope, discussions may be focused towards an enhanced pledge from India as a donor to The Global Fund.

This has been communicated by Mr Peter Sands, Executive Director, the Global Fund, in a side line bilateral meeting at the level of Secretary HFW in Geneva on the aegis of the World Health Assembly

Global Fund Grant Adjustments and Reprioritization:

The Global Fund, through several communications addressed to the Principal Recipients and Secretary HFW have intimated that significant and rapid changes in the external financing landscape for global health programs have resulted in disruptions to health services and volatility across the global health eco-system. There is significant uncertainty about ongoing support for bilateral and multilateral health programs, including the Global Fund.
The Global Fund Board has discussed the overall approach to reprioritization and reinvestment at its Global Fund Board Meeting held on 7th to 9th May 2025. The key takeaways from the Board meeting are as follows:
  • Prioritization of Life saving interventions amid crisis through a country -driven process involving meaningful engagement with civil society, communities Ministry of Health, implementers, technical partners and key structures across the partnership- in particular the Country Coordinating Mechanisms. Reprioritization should be guided by equity, efficiency and protection of impact.
  • Long term sustainability, wherein the Board encouraged responsible and gradual transitions towards increased domestic financing and urged the Global Fund to strengthen alignment and coordination with partners, especially Gavi.
  • Strong Eighth replenishment to protect progress, wherein the Board called out for strong support from all partners to make ambitious pledges, increased domestic health financing and contributing skills, investment and advocacy.
  • Spain pledged €145 million, and Luxembourg pledged €13.8 million – both marking an increase over their respective commitments at the Global Fund’s Seventh Replenishment in 2022. Norway has announced a renewed pledge of NOK 2 billion to the Global Fund) for the next replenishment cycle
  • Takeda Pharmaceutical Company, a Japan-based global leader in pharmaceuticals has committed an amount of JPY 350 million. This marks the first corporate commitment to the Global Fund’s Eighth Replenishment

A communication dated 27th June is received from the Global Fund, where the India grant for GC7 has been cut down from 504 mUSD to 432.53 mUSD

Get In Touch

India CCM Secretariat, National Aids Control Organisation (NACO), Ministry of Health & Family Welfare 9th Floor, Janpath, New Delhi- 110001 India

Telefax No: 91 11 43509905 E-mail: iccmsect-mohfw[at]gov[dot]in

CONTACT US